ROBERT PLEYO: Open Payments
NPI 1861631384 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 15 payments from 9 companies in 2025. Trend: 2023 $3,296 · 2024 $772 · 2025 $1,126
Food & beverage: $1,126
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $270 |
| AstraZeneca Pharmaceuticals LP | 3 | $214 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $144 |
| Medtronic, Inc. | 1 | $130 |
| Amgen Inc. | 1 | $123 |
| Novo Nordisk Inc | 1 | $122 |
| Travere Therapeutics, Inc. | 1 | $92 |
| Ardelyx, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: JARDIANCE, SYMPLICITY G3, TAVNEOS, Ozempic, VOYXACT, JYNARQUE, LOKELMA, FARXIGA.
Industry payments across WA — which companies pay providers there.
